Related references
Note: Only part of the references are listed.ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway
Cristina E. Tognon et al.
CANCER RESEARCH (2011)
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma
Fabio Forghieri et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Mammary-type Secretory Carcinoma of the Skin
Dmitry V. Kazakov et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Visualization of molecular interactions using bimolecular fluorescence complementation analysis: Characteristics of protein fragment complementation
Tom K. Kerppola
CHEMICAL SOCIETY REVIEWS (2009)
The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase
MJ Martin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Discovery of a 1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
M Wittman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The insulin-like growth factor-1 receptor as a target for cancer therapy
R Baserga
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
ETV6-NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages
CL Lannon et al.
SEMINARS IN CANCER BIOLOGY (2005)
A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1 - An essential interaction for transformation
CL Lannon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells
HZ Sun et al.
ENDOCRINOLOGY (2004)
Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity
CE Tognon et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon et al.
CANCER CELL (2002)
ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation
KB Morrison et al.
ONCOGENE (2002)
The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells
DH Wai et al.
ONCOGENE (2000)
Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: Application to challenging pediatric renal stromal tumors
P Argani et al.
MODERN PATHOLOGY (2000)
Share Paper
